This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2003 Jun;41(6):1334; author reply 1334-5.

doi: 10.1016/s0272-6386(03)00511-0.

Dosing darbepoetin alfa continued

PMID: 12776288
DOI: 10.1016/s0272-6386(03)00511-0

Comparative Study

Dosing darbepoetin alfa continued

Gilbert Deray. Am J Kidney Dis. 2003 Jun.

. 2003 Jun;41(6):1334; author reply 1334-5.

doi: 10.1016/s0272-6386(03)00511-0.

Author

PMID: 12776288
DOI: 10.1016/s0272-6386(03)00511-0

No abstract available

PubMed Disclaimer

Comment on

Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients.
Nissenson AR, Swan SK, Lindberg JS, Soroka SD, Beatey R, Wang C, Picarello N, McDermott-Vitak A, Maroni BJ. Nissenson AR, et al. Am J Kidney Dis. 2002 Jul;40(1):110-8. doi: 10.1053/ajkd.2002.33919. Am J Kidney Dis. 2002. PMID: 12087568 Clinical Trial.
Dosing darbepoetin alfa.
Nissenson AR. Nissenson AR. Am J Kidney Dis. 2002 Oct;40(4):872. doi: 10.1053/ajkd.2002.36566. Am J Kidney Dis. 2002. PMID: 12324929 No abstract available.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science